valcyte使用说明

Valganciclovir Hydrochloride Tablets () are indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). Valganciclovir hydrochloride tablets (valcyte) are suitable for preventing CMV infection in high-risk solid organ transplant patients. Next, let’s learn about the instructions for using valganciclovir hydrochloride tablets (valcyte).

Adult patients should take valganciclovir hydrochloride tablets (valcyte) with food. Valganciclovir hydrochloride tablets (valcyte) should not be broken or crushed. Recommended dose in adults with normal renal function: Treatment of induction of cytomegalovirus retinitis: The recommended dose is 900 mg (two 450 mg tablets) twice daily for 21 days. Maintenance: After induction therapy, or in adult patients with inactive cytomegalovirus retinitis, the recommended dose is 900 mg orally once daily. Cytomegalovirus prophylaxis: For adult patients who have received a heart or kidney-pancreas transplant, the recommended dose is 900 mg orally once daily starting within 10 days of transplantation and continuing until 100 days after transplantation. For adult patients who have received a kidney transplant, the recommended dose is 900 mg taken orally once daily starting within 10 days after transplantation and until 200 days after transplantation. Recommended Dosage in Pediatric Patients: Cytomegalovirus (CMV) Prophylaxis in Pediatric Renal Transplant Patients: For pediatric renal transplant patients 4 months to 16 years of age, the recommended once-daily mg dose (7 × BSA (bovine serum albumin) × CrCl (creatinine clearance)) should be initiated within 10 days after transplantation and continued until 200 days after transplantation. Prophylaxis of Cytomegalovirus (CMV) in Pediatric Heart Transplant Patients: For pediatric heart transplant patients 1 month to 16 years of age, a once-daily mg dose (7 × BSA (bovine serum albumin) × CrCl (creatinine clearance)) is recommended starting within 10 days after transplantation and continuing until day 100 after transplantation. The above are the instructions for use of Valganciclovir Hydrochloride Tablets ().